JP2024529434A5 - - Google Patents
Info
- Publication number
- JP2024529434A5 JP2024529434A5 JP2024504774A JP2024504774A JP2024529434A5 JP 2024529434 A5 JP2024529434 A5 JP 2024529434A5 JP 2024504774 A JP2024504774 A JP 2024504774A JP 2024504774 A JP2024504774 A JP 2024504774A JP 2024529434 A5 JP2024529434 A5 JP 2024529434A5
- Authority
- JP
- Japan
- Prior art keywords
- score
- antibody
- pharmaceutical composition
- subject
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225716P | 2021-07-26 | 2021-07-26 | |
| US63/225,716 | 2021-07-26 | ||
| US202163240734P | 2021-09-03 | 2021-09-03 | |
| US63/240,734 | 2021-09-03 | ||
| US202263313041P | 2022-02-23 | 2022-02-23 | |
| US63/313,041 | 2022-02-23 | ||
| EP22315049.1 | 2022-03-04 | ||
| EP22315049 | 2022-03-04 | ||
| US202263353654P | 2022-06-20 | 2022-06-20 | |
| US63/353,654 | 2022-06-20 | ||
| PCT/US2022/038185 WO2023009437A1 (en) | 2021-07-26 | 2022-07-25 | Methods for treating chronic spontaneous urticaria by administering an il-4r antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529434A JP2024529434A (ja) | 2024-08-06 |
| JP2024529434A5 true JP2024529434A5 (https=) | 2025-08-01 |
Family
ID=82899210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504774A Pending JP2024529434A (ja) | 2021-07-26 | 2022-07-25 | Ｉｌ－４ｒアンタゴニストを投与することによる慢性自発性蕁麻疹を治療するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230146317A1 (https=) |
| EP (1) | EP4377345A1 (https=) |
| JP (1) | JP2024529434A (https=) |
| KR (1) | KR20240037321A (https=) |
| AU (1) | AU2022316939A1 (https=) |
| CA (1) | CA3226781A1 (https=) |
| IL (1) | IL310362A (https=) |
| MX (1) | MX2024001189A (https=) |
| WO (1) | WO2023009437A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9574004B2 (en) | 2012-08-21 | 2017-02-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an IL-4R antagonist |
| BR112022000740A2 (pt) | 2019-07-16 | 2022-07-05 | Sanofi Biotechnology | Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r |
| WO2025088063A2 (en) * | 2023-10-24 | 2025-05-01 | Sanofi | Systems and methods for monitoring a medicament dosing schedule |
| KR20250118250A (ko) * | 2024-01-26 | 2025-08-06 | 연세대학교 산학협력단 | 식물에서 발현된 항-IL-4Rα 항체의 항원결합 단편 및 이의 용도 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US8178098B2 (en) | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| MY149079A (en) | 2006-10-02 | 2013-07-15 | Regeneron Pharma | High affinity human antibodies to human il-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| NZ609557A (en) | 2010-10-06 | 2014-12-24 | Regeneron Pharma | Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies |
| TWI633891B (zh) * | 2013-06-04 | 2018-09-01 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法 |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CA3132587A1 (en) * | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
-
2022
- 2022-07-25 IL IL310362A patent/IL310362A/en unknown
- 2022-07-25 AU AU2022316939A patent/AU2022316939A1/en active Pending
- 2022-07-25 JP JP2024504774A patent/JP2024529434A/ja active Pending
- 2022-07-25 US US17/872,225 patent/US20230146317A1/en active Pending
- 2022-07-25 MX MX2024001189A patent/MX2024001189A/es unknown
- 2022-07-25 WO PCT/US2022/038185 patent/WO2023009437A1/en not_active Ceased
- 2022-07-25 EP EP22754671.0A patent/EP4377345A1/en active Pending
- 2022-07-25 CA CA3226781A patent/CA3226781A1/en active Pending
- 2022-07-25 KR KR1020247006130A patent/KR20240037321A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529434A5 (https=) | ||
| de Oliveira Rocha et al. | Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: a double-blind randomized controlled study | |
| Foss et al. | Fascia iliaca compartment blockade for acute pain control in hip fracture patients: a randomized, placebo-controlled trial | |
| Mitchell et al. | A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial | |
| RU2012117563A (ru) | Режим дозирования модулятора рецептора s1p | |
| Chen et al. | Oral diazepam versus intravenous midazolam for conscious sedation during cataract surgery performed using topical anesthesia | |
| KR20150003765A (ko) | 라퀴니모드와 디메틸 푸마레이트의 병용물에 의한 다발성 경화증의 치료 | |
| CN104602689A (zh) | 生物素治疗多发性硬化的用途 | |
| AU2025203339A1 (en) | Therapeutic Uses of Tirzepatide | |
| CN119421702A (zh) | 替尔泊肽组合物和用途 | |
| Cohen | Emerging therapies for relapsing multiple sclerosis | |
| JP2025072354A (ja) | チルゼパチド治療方法 | |
| KR20170131543A (ko) | 근위축성 측삭 경화증을 치료하기 위한 비오틴 | |
| AU2013290181A1 (en) | Treatment of multiple sclerosis with combination of laquinimod and fampridine | |
| Marcon et al. | Effects of ganglioside G (M1) and erythropoietin on spinal cord lesions in rats: functional and histological evaluations | |
| TW201211021A (en) | Methods of use of cyclic amide derivatives to treat schizophrenia | |
| Harned et al. | An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases | |
| Fryman et al. | Guillain-Barré syndrome induced dysautonomia resulting in cardiac arrest | |
| MEYER et al. | Influence of norethynodrel with mestranol on intraocular pressure in glaucoma: II. A controlled double-blind study | |
| Ryan et al. | Providing pharmaceutical care to the multiple sclerosis patient | |
| JP4775940B2 (ja) | アロディニアの治療、改善、予防剤 | |
| Cheesman | Sickle cell disease: symptoms, complications and management | |
| JP7579027B2 (ja) | セスキテルペンラクトン系化合物の視神経炎治療薬の製造における使用 | |
| Kandimalla et al. | INTRATHECAL HYPERBARIC LEVOBUPIVACAINE (0.5%) VS HYPERBARIC ROPIVACAINE (0.75%) FOR PERIANAL SURGERIES–A RANDOMISED CONTROLLED TRIAL. | |
| RU2024104460A (ru) | Способы лечения хронической спонтанной крапивницы путем введения антагониста il-4r |